GLP 1 News and Research

RSS
Incretin-based drugs do not increase risk of heart failure

Incretin-based drugs do not increase risk of heart failure

BioAgilytix announces acquisition of IPM Biotech

BioAgilytix announces acquisition of IPM Biotech

Drug combination improves glucose control in Type 2 diabetes patients

Drug combination improves glucose control in Type 2 diabetes patients

IDegLira injections more effective than traditional insulin injections in treating type-2 diabetes patients

IDegLira injections more effective than traditional insulin injections in treating type-2 diabetes patients

Isomaltulose more suitable than table sugar for people with type 2 diabetes

Isomaltulose more suitable than table sugar for people with type 2 diabetes

Penn investigators explore new treatment option for cocaine dependence

Penn investigators explore new treatment option for cocaine dependence

Study provides new insight into complex interchange that can raise blood levels of fat in type 1 diabetes

Study provides new insight into complex interchange that can raise blood levels of fat in type 1 diabetes

UM SOM selected to work with BARDA to develop radiologic and nuclear countermeasures

UM SOM selected to work with BARDA to develop radiologic and nuclear countermeasures

Jubilant Biosys, Sanofi partner to develop small molecule inhibitors in metabolic disorders therapeutic area

Jubilant Biosys, Sanofi partner to develop small molecule inhibitors in metabolic disorders therapeutic area

Rani Therapeutics, MedImmune collaborate to evaluate novel oral drug delivery platform

Rani Therapeutics, MedImmune collaborate to evaluate novel oral drug delivery platform

New class of diabetes drugs differs in efficacy and safety profiles, shows new research

New class of diabetes drugs differs in efficacy and safety profiles, shows new research

TSRI scientists use new drug discovery technique to identify anti-diabetes compound

TSRI scientists use new drug discovery technique to identify anti-diabetes compound

IQWiG finds no added benefit for insulin degludec/liraglutide in adults with type 2 diabetes

IQWiG finds no added benefit for insulin degludec/liraglutide in adults with type 2 diabetes

Diabetes drug liraglutide ineffective in patients with advanced heart failure

Diabetes drug liraglutide ineffective in patients with advanced heart failure

New generation of incretin-based medicines allows coordinated action against diabesity

New generation of incretin-based medicines allows coordinated action against diabesity

Type-2 diabetes medication can affect the brain's reward system, reduce intake of food

Type-2 diabetes medication can affect the brain's reward system, reduce intake of food

Medication used for diabetes could be a valuable tool for treating alcohol dependence

Medication used for diabetes could be a valuable tool for treating alcohol dependence

New study highlights gap in scientific knowledge about some diabetes drugs

New study highlights gap in scientific knowledge about some diabetes drugs

AstraZeneca presents safety and efficacy data for ExQW at 51st Annual Meeting of EASD

AstraZeneca presents safety and efficacy data for ExQW at 51st Annual Meeting of EASD

ELIXA trial results demonstrate cardiovascular safety of lixisenatide drug

ELIXA trial results demonstrate cardiovascular safety of lixisenatide drug